Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMI vs CEUS for Spoke-wheel Sign in FNH
NCT02737865Completed
- Sponsor
- Samsung Medical Center
- Start
- May 2016
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Samsung Medical Center. Primary endpoint: Grading of spoke-wheel sign on CEUS using sonazoid and SMI at 1 day. Started May 2016; status: completed.
Beyond the preview
Go deeper on NCT02737865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737865.